Mike Burgess, Senior Vice President, Research at Bristol Myers Squibb, shared on LinkedIn:
“It was an honor to introduce Kristen Hege, alongside my friend and colleague Michael Pourdehnad, as Kristen was inducted as a Fellow of SITC’s Academy of Immuno-Oncology.
Kristen is a friend, mentor, CAR T pioneer, champion of women in science, and avid thru-hiker. Such a treat to celebrate with her at Society for Immunotherapy of Cancer (SITC) 2026!”
You can also read:
Bernard Fox: A New Approach to Predicting Tumor Immunity from H&E Slides
